OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	37
Dual organ transplantation: Pancreas and Liver in the kidney axis	35
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	30
Editorial introductions	25
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	24
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	24
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	23
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	23
Interferon gamma in the pathogenesis of hypertension − recent insights	23
The impact of conflicts on patients with chronic kidney disease	20
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	20
Maximizing opportunities for kidney transplantation in older adults	19
Editorial introduction	18
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	18
International equity in access to home dialysis	17
Prediction models for earlier stages of chronic kidney disease	17
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	17
Renal denervation for the treatment of hypertension and kidney disease	16
Modern indications for referral for kidney and pancreas transplantation	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	15
Bringing the end-stage kidney disease life plan home	15
Plant-based diets for kidney disease prevention and treatment	14
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	14

The race coefficient in glomerular filtration rate-estimating equations and its removal	13
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	13
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	13
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	12
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	12
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	11
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	11
Built environment and chronic kidney disease: current state and future directions	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	11
Understanding renal phosphate handling: unfinished business	10
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	10
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	10
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	10
Combination therapy with kidney protective therapies: optimizing the benefits?	10
Complement detection in kidney biopsies – utility and challenges	10
Editorial introductions	10
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	9
When the earth shakes unexpectedly: impact on nephrology services and patients	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	9
Automation and innovation in home hemodialysis machines	9
Climate change and kidney stones	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Cancer drugs and acute kidney injury: new therapies and new challenges	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
A guide for program development of environmentally sustainable kidney care	9
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	8
Evolving thresholds for the diagnosis of acute T cell mediated rejection	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
Impact of intensive blood pressure control on kidney outcomes	8
The current therapeutic approach for anaemia after kidney transplant	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Deep learning applications for kidney histology analysis	8
New and old approaches to nutritional management of acute and chronic glomerulonephritis	8
Sex differences in renal electrolyte transport	7
Editorial introduction	7
Recent advances in treatment options for kidney disease	7
Hypernatremia in the intensive care unit	7
Prospects for gene therapy in polycystic kidney disease	7
Editorial introductions	7
Editorial introductions	7
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	7
New insights into renal calcium-sensing receptor activation	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7
Renal osteodystrophy: something old, something new, something needed	7

Vaccination in kidney disease: what did we learn from COVID-19 pandemic	7
Evolving indications and management patterns in heart – kidney transplantation	6
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	6
Novel approaches in antihypertensive pharmacotherapeutics	6
Renal denervation: recent developments in clinical and preclinical research	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
Novel intestinal dialysis interventions and microbiome modulation to control uremia	6
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Contemporary risk prediction models in chronic kidney disease: when less is more	6
The genetics of cystinuria – an update and critical reevaluation	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Building kidney organoids from pluripotent stem cells	6